Efficacy and safety of a new intravenous immunoglobulin 10% formulation (octagam® 10%) in patients with immune thrombocytopenia.

Efficacy and safety of a new intravenous immunoglobulin 10% formulation (octagam® 10%) in patients with immune thrombocytopenia.

Item
http://www.wikidata.org/entity/Q33391987
Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic reviewImmune thrombocytopenia -- what are the new treatment options?Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study.Safety and efficacy of a 10% intravenous immunoglobulin preparation in patients with immune thrombocytopenic purpura: results of two international, multicenter studies.New aspects on the efficacy of high-dose intravenous immunoglobulins in patients with autoimmune thrombocytopenia.Therapeutic plasma proteins--application of proteomics in process optimization, validation, and analysis of the final product.10% liquid human immunoglobulin (KIOVIG(®)) for immunomodulation in autoimmune disorders.Biologics in dermatology: adverse effects.Surveillance study on the tolerability and safety of Flebogamma® DIF (10% and 5% intravenous immunoglobulin) in adult and pediatric patients.Tolerability and safety of the intravenous immunoglobulin octagam(®) 10% in patients with immune thrombocytopenia: a post-authorisation safety analysis of two non-interventional phase IV trials.An open, prospective trial investigating the pharmacokinetics and safety, and the tolerability of escalating infusion rates of a 10% human normal immunoglobulin for intravenous infusion (IVIg), BT090, in patients with primary immunodeficiency diseasEfficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP).
P2860

Efficacy and safety of a new intravenous immunoglobulin 10% formulation (octagam® 10%) in patients with immune thrombocytopenia.

Item
http://www.wikidata.org/entity/Q33391987
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Efficacy and safety of a new i ...... with immune thrombocytopenia.
@ast
Efficacy and safety of a new i ...... with immune thrombocytopenia.
@en
type
label
Efficacy and safety of a new i ...... with immune thrombocytopenia.
@ast
Efficacy and safety of a new i ...... with immune thrombocytopenia.
@en
prefLabel
Efficacy and safety of a new i ...... with immune thrombocytopenia.
@ast
Efficacy and safety of a new i ...... with immune thrombocytopenia.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Efficacy and safety of a new i ...... with immune thrombocytopenia.
@en
P2093
P2860
P304
P31
P356
10.1179/102453310X12719010991867
P433
P478
P50
P577
P698
P921